RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 794 filers reported holding RAYTHEON CO in Q3 2014. The put-call ratio across all filers is 1.70 and the average weighting 0.3%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,549,000 | -1.8% | 7,897 | -12.9% | 0.08% | -3.6% |
Q2 2019 | $1,577,000 | -7.5% | 9,067 | -3.2% | 0.08% | -3.4% |
Q1 2019 | $1,705,000 | +22.0% | 9,362 | +2.7% | 0.09% | +7.4% |
Q4 2018 | $1,397,000 | -23.7% | 9,112 | +2.8% | 0.08% | +2.5% |
Q3 2018 | $1,832,000 | +24.0% | 8,864 | +15.9% | 0.08% | +113.5% |
Q2 2018 | $1,477,000 | -10.5% | 7,647 | -0.1% | 0.04% | -11.9% |
Q1 2018 | $1,651,000 | +14.9% | 7,652 | +0.1% | 0.04% | +35.5% |
Q4 2017 | $1,437,000 | -1.5% | 7,647 | -2.2% | 0.03% | -6.1% |
Q3 2017 | $1,459,000 | +15.2% | 7,822 | -0.3% | 0.03% | +13.8% |
Q2 2017 | $1,267,000 | +25.2% | 7,847 | +18.2% | 0.03% | +20.8% |
Q1 2017 | $1,012,000 | +6.3% | 6,638 | -1.0% | 0.02% | +4.3% |
Q4 2016 | $952,000 | +6.1% | 6,702 | +1.7% | 0.02% | +4.5% |
Q3 2016 | $897,000 | -3.5% | 6,592 | -3.7% | 0.02% | -4.3% |
Q2 2016 | $930,000 | +10.7% | 6,842 | -0.1% | 0.02% | +9.5% |
Q1 2016 | $840,000 | +1.8% | 6,852 | +3.4% | 0.02% | +10.5% |
Q4 2015 | $825,000 | +4.8% | 6,627 | -8.0% | 0.02% | -36.7% |
Q3 2015 | $787,000 | +14.2% | 7,201 | 0.0% | 0.03% | +3.4% |
Q2 2015 | $689,000 | -10.3% | 7,201 | +2.4% | 0.03% | -3.3% |
Q1 2015 | $768,000 | +6.2% | 7,034 | +5.2% | 0.03% | 0.0% |
Q4 2014 | $723,000 | +2.8% | 6,684 | -3.4% | 0.03% | 0.0% |
Q3 2014 | $703,000 | +14.3% | 6,919 | +3.7% | 0.03% | +15.4% |
Q2 2014 | $615,000 | -8.1% | 6,669 | -1.6% | 0.03% | -13.3% |
Q1 2014 | $669,000 | +4.5% | 6,774 | -4.0% | 0.03% | -3.2% |
Q4 2013 | $640,000 | +44.8% | 7,054 | +22.9% | 0.03% | +34.8% |
Q3 2013 | $442,000 | +18.5% | 5,739 | +1.8% | 0.02% | +27.8% |
Q2 2013 | $373,000 | – | 5,638 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |